Jurox Offers Veterinary Practices Support Following Propofol Product Recall
7 years ago 
1291 views
Following the second major shortage of the UK’s most widely used veterinary licensed propofol (Inductofol and Vetofol, Norbrook) in just 18 months, Jurox (UK) Ltd can confirm its commitment to supporting practices wishing to use Alfaxan.
Alfaxan 10mg/mL solution for injection for dogs and cats is licensed as an induction agent prior to inhalation anaesthesia and as a sole anaesthetic agent for the induction and maintenance of anaesthesia for the performance of examination or surgical procedures.
Unlike veterinary licensed formulations of propofol containing preservative, Alfaxan has been safely used:
- in patients from 12 weeks of age,
- for the induction of anaesthesia prior to delivery of puppies by caesarean section and
- for maintenance anaesthesia in procedures lasting up to an hour.
As part of Jurox’s commitment to support vets and nurses with their anaesthesia, it offers the following advice:
Part 1 (2) of Schedule 4 of the Veterinary Medicines Regulations states that ‘if there is no authorised veterinary medicinal product’ then the cascade may be followed. Alfaxan® is an available and authorised veterinary medicinal product with very similar indications and therefore there is no clinical need to resort to non-licensed formulations of propofol, under cascade, for veterinary intravenous anaesthesia.
The Jurox UK team of vets will once again respond proactively to this propofol shortage by delivering educational support to veterinary professionals and assisting them through the simple change to another veterinary licensed product for the anaesthesia of cats and dogs should they wish. Jurox invites practitioners to contact its team of vets if they would like to discuss specific cases or need education and support in using Alfaxan for the first time.
Please contact us for more information on 0800 500 3171 or email [email protected].
More from Jurox (UK) Ltd
